First National Advisers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Sell
11,987
-800
-6% -$221K 0.37% 73
2026
Q1
$3.78M Sell
12,787
-1,986
-13% -$590K 0.55% 42
2025
Q4
$4.03M Sell
14,773
-277
-2% -$75.3K 0.55% 42
2025
Q3
$4.07M Buy
15,050
+373
+3% +$101K 0.55% 46
2025
Q2
$4.05M Buy
14,677
+14
+0.1% +$3.81K 0.59% 45
2025
Q1
$3.89M Sell
14,663
-206
-1% -$50.8K 0.62% 45
2024
Q4
$3.45M Sell
14,869
-2,271
-13% -$522K 0.56% 48
2024
Q3
$3.78M Buy
17,140
+616
+4% +$127K 0.6% 46
2024
Q2
$3.25M Buy
16,524
+2,240
+16% +$463K 0.59% 51
2024
Q1
$2.96M Buy
14,284
+1,834
+15% +$385K 0.66% 44
2023
Q4
$2.62M Buy
12,450
+3,749
+43% +$800K 0.75% 41
2023
Q3
$1.74M Buy
8,701
+3,779
+77% +$751K 0.78% 35
2023
Q2
$912K Buy
4,922
+57
+1% +$10.5K 0.84% 42
2023
Q1
$932K Buy
4,865
+426
+10% +$77K 1.06% 29
2022
Q4
$747K Buy
4,439
+1,955
+79% +$340K 0.96% 38
2022
Q3
$440K Buy
2,484
+712
+40% +$141K 0.65% 56
2022
Q2
$363K Buy
+1,772
New +$376K 0.75% 53

Other funds holding CME

First National Advisers's CME Position: Q2 2026 in Review

First National Advisers reduced its CME Group (CME) stake by 6.3% in Q2 2026, selling an estimated $221K and leaving 11,987 shares worth $2.65M. The position accounts for 0.37% of the portfolio, ranked #73.

First National Advisers first reported a position in CME in Q2 2022 and has held it in 17 quarters since. The position peaked at $4.07M in Q3 2025. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • First National Advisers held 11,987 shares of CME Group worth $2.65M as of Q2 2026.
  • First National Advisers sold 800 CME Group shares in Q2 2026, an estimated $221K.
  • CME Group made up 0.37% of First National Advisers's portfolio in Q2 2026, its #73 holding.
  • First National Advisers first reported a position in CME Group in Q2 2022 and has held it in 17 quarters since.
  • First National Advisers's CME Group position peaked at $4.07M in Q3 2025.
  • 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on First National Advisers's 13F filing for Q2 2026, filed 21 Jul 2026.